347 related articles for article (PubMed ID: 26831084)
1. Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.
Patial S; Curtis AD; Lai WS; Stumpo DJ; Hill GD; Flake GP; Mannie MD; Blackshear PJ
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1865-70. PubMed ID: 26831084
[TBL] [Abstract][Full Text] [Related]
2. 3'UTR AU-Rich Elements (AREs) and the RNA-Binding Protein Tristetraprolin (TTP) Are Not Required for the LPS-Mediated Destabilization of Phospholipase-Cβ-2 mRNA in Murine Macrophages.
Shukla S; Elson G; Blackshear PJ; Lutz CS; Leibovich SJ
Inflammation; 2017 Apr; 40(2):645-656. PubMed ID: 28124257
[TBL] [Abstract][Full Text] [Related]
3. Tristetraprolin (TTP) coordinately regulates primary and secondary cellular responses to proinflammatory stimuli.
Qiu LQ; Lai WS; Bradbury A; Zeldin DC; Blackshear PJ
J Leukoc Biol; 2015 Apr; 97(4):723-36. PubMed ID: 25657290
[TBL] [Abstract][Full Text] [Related]
4. Regulated Tristetraprolin Overexpression Dampens the Development and Pathogenesis of Experimental Autoimmune Uveitis.
Xu B; Tang J; Lyu C; Wandu WS; Stumpo DJ; Mattapallil MJ; Horai R; Gery I; Blackshear PJ; Caspi RR
Front Immunol; 2020; 11():583510. PubMed ID: 33569048
[TBL] [Abstract][Full Text] [Related]
5. Bi-phased regulation of the post-transcriptional inflammatory response by Tristetraprolin levels.
Mahmoud L; Moghrabi W; Khabar KSA; Hitti EG
RNA Biol; 2019 Mar; 16(3):309-319. PubMed ID: 30664390
[TBL] [Abstract][Full Text] [Related]
6. Tristetraprolin overexpression drives hematopoietic changes in young and middle-aged mice generating dominant mitigating effects on induced inflammation in murine models.
Tanaka-Yano M; Zong L; Park B; Yanai H; Tekin-Turhan F; Blackshear PJ; Beerman I
Geroscience; 2024 Feb; 46(1):1271-1284. PubMed ID: 37535204
[TBL] [Abstract][Full Text] [Related]
7. A Knock-In Tristetraprolin (TTP) Zinc Finger Point Mutation in Mice: Comparison with Complete TTP Deficiency.
Lai WS; Stumpo DJ; Qiu L; Faccio R; Blackshear PJ
Mol Cell Biol; 2018 Feb; 38(4):. PubMed ID: 29203639
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of tristetraprolin (TTP) modulation in the treatment of inflammatory diseases.
Snyder BL; Blackshear PJ
Pharmacol Ther; 2022 Nov; 239():108198. PubMed ID: 35525391
[TBL] [Abstract][Full Text] [Related]
9. The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis.
Carrick DM; Lai WS; Blackshear PJ
Arthritis Res Ther; 2004; 6(6):248-64. PubMed ID: 15535838
[TBL] [Abstract][Full Text] [Related]
10. Tristetraprolin as a Therapeutic Target in Inflammatory Disease.
Patial S; Blackshear PJ
Trends Pharmacol Sci; 2016 Oct; 37(10):811-821. PubMed ID: 27503556
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-specific tristetraprolin deficiency in mice results in extreme lipopolysaccharide sensitivity in an otherwise minimal phenotype.
Qiu LQ; Stumpo DJ; Blackshear PJ
J Immunol; 2012 May; 188(10):5150-9. PubMed ID: 22491258
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
[TBL] [Abstract][Full Text] [Related]
13. Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3' untranslated region.
Zhao W; Liu M; D'Silva NJ; Kirkwood KL
J Interferon Cytokine Res; 2011 Aug; 31(8):629-37. PubMed ID: 21457063
[TBL] [Abstract][Full Text] [Related]
14. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts.
Lai WS; Parker JS; Grissom SF; Stumpo DJ; Blackshear PJ
Mol Cell Biol; 2006 Dec; 26(24):9196-208. PubMed ID: 17030620
[TBL] [Abstract][Full Text] [Related]
15. Tristetraprolin Limits Inflammatory Cytokine Production in Tumor-Associated Macrophages in an mRNA Decay-Independent Manner.
Kratochvill F; Gratz N; Qualls JE; Van De Velde LA; Chi H; Kovarik P; Murray PJ
Cancer Res; 2015 Aug; 75(15):3054-64. PubMed ID: 26183929
[TBL] [Abstract][Full Text] [Related]
16. Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family.
Stumpo DJ; Byrd NA; Phillips RS; Ghosh S; Maronpot RR; Castranio T; Meyers EN; Mishina Y; Blackshear PJ
Mol Cell Biol; 2004 Jul; 24(14):6445-55. PubMed ID: 15226444
[TBL] [Abstract][Full Text] [Related]
17. Life without TTP: apparent absence of an important anti-inflammatory protein in birds.
Lai WS; Stumpo DJ; Kennington EA; Burkholder AB; Ward JM; Fargo DL; Blackshear PJ
Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R689-700. PubMed ID: 23904106
[TBL] [Abstract][Full Text] [Related]
18. Insulin increases tristetraprolin and decreases VEGF gene expression in mouse 3T3-L1 adipocytes.
Cao H; Urban JF; Anderson RA
Obesity (Silver Spring); 2008 Jun; 16(6):1208-18. PubMed ID: 18388887
[TBL] [Abstract][Full Text] [Related]
19. Tristetraprolin regulates CXCL1 (KC) mRNA stability.
Datta S; Biswas R; Novotny M; Pavicic PG; Herjan T; Mandal P; Hamilton TA
J Immunol; 2008 Feb; 180(4):2545-52. PubMed ID: 18250465
[TBL] [Abstract][Full Text] [Related]
20. Zinc finger protein tristetraprolin interacts with CCL3 mRNA and regulates tissue inflammation.
Kang JG; Amar MJ; Remaley AT; Kwon J; Blackshear PJ; Wang PY; Hwang PM
J Immunol; 2011 Sep; 187(5):2696-701. PubMed ID: 21784977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
